|Home||» Products||» Sofosbuvir||» Zydus Launch SoviHep|
Zydus Launch SoviHep
Having both quality and clients centric approach, we have been occupied in exporting and supplying a premium range of Zydus Launch SoviHep. This product is formulated using quality approved chemical compounds by ingenious professionals as per set medical standards. Offered product is widely prescribed by doctors for treating of hepatitis C virus, that spreads due to blood contact and further leads to failure of lung. Additionally, our precious clients can buy this Zydus Launch SoviHep from us at most remarkable costs.
- Highly effective
- Free from harmful impurities
- Longer shelf life
- Fewer side effects
Zydus and Gilead Sciences Inc has signed a non-exclusive licensing agreement which will allow the manufacture of sofosbuvir and the fixed-dose combination of ledipasvir/sofosbuvir for distribution in 91 countries including India. The company said that the oral therapy would be able to help more than 10 million patients who suffer from Hepatitis C in India.